Gene therapy for Parkinson's disease
Identifieur interne : 000706 ( Main/Exploration ); précédent : 000705; suivant : 000707Gene therapy for Parkinson's disease
Auteurs : Tomas Bjorklund [Suède] ; Jeffrey H. Kordower [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2010.
English descriptors
Abstract
The once fantastic theoretical concept that patients with Parkinson's disease (PD) would receive gene therapy in an attempt to alleviate their symptoms and potentially modify the course of their disease has become a reality. On the basis of positive preclinical data, four different gene therapy approaches are currently in Phase I or Phase II clinical trials. Some approaches are intended to increase levels of endogenous dopamine or enhance the function of the prodrug levodopa. Others are intended to normalize basal ganglia circuitry by reducing the PD‐related overactivity of specific brain structures such as the subthalamic nucleus. Each is intended for symptomatic benefit. Finally, gene delivery of trophic factors that not only augment dopaminergic function but are potentially disease modifying has a strong preclinical database and are also in clinical trials. Each of these approaches is discussed in the present review. © 2010 Movement Disorder Society
Url:
DOI: 10.1002/mds.22785
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Gene therapy for Parkinson's disease</title><author><name sortKey="Bjorklund, Tomas" sort="Bjorklund, Tomas" uniqKey="Bjorklund T" first="Tomas" last="Bjorklund">Tomas Bjorklund</name></author><author><name sortKey="Kordower, Jeffrey H" sort="Kordower, Jeffrey H" uniqKey="Kordower J" first="Jeffrey H." last="Kordower">Jeffrey H. Kordower</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:AAC2F34BFA188D448A90DEC60A14E1BB44F09B51</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1002/mds.22785</idno><idno type="url">https://api.istex.fr/document/AAC2F34BFA188D448A90DEC60A14E1BB44F09B51/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001D47</idno><idno type="wicri:Area/Main/Curation">001A67</idno><idno type="wicri:Area/Main/Exploration">000706</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Gene therapy for Parkinson's disease</title><author><name sortKey="Bjorklund, Tomas" sort="Bjorklund, Tomas" uniqKey="Bjorklund T" first="Tomas" last="Bjorklund">Tomas Bjorklund</name><affiliation wicri:level="1"><country xml:lang="fr">Suède</country><wicri:regionArea>Brain Repair and Imaging in Neural Systems (B.R.A.I.N.S Unit), Department of Experimental and Medical Science, Lund University, Lund</wicri:regionArea><wicri:noRegion>Lund</wicri:noRegion></affiliation></author><author><name sortKey="Kordower, Jeffrey H" sort="Kordower, Jeffrey H" uniqKey="Kordower J" first="Jeffrey H." last="Kordower">Jeffrey H. Kordower</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurological Sciences, Rush University Medical Center, Chicago Illinois</wicri:regionArea><wicri:noRegion>Chicago Illinois</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2010">2010</date><biblScope unit="volume">25</biblScope><biblScope unit="issue">S1</biblScope><biblScope unit="page" from="S161">S161</biblScope><biblScope unit="page" to="S173">S173</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">AAC2F34BFA188D448A90DEC60A14E1BB44F09B51</idno><idno type="DOI">10.1002/mds.22785</idno><idno type="ArticleID">MDS22785</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>clinical trials</term><term>dopamine</term><term>gene therapy</term><term>nonhuman primates</term><term>trophic factors</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The once fantastic theoretical concept that patients with Parkinson's disease (PD) would receive gene therapy in an attempt to alleviate their symptoms and potentially modify the course of their disease has become a reality. On the basis of positive preclinical data, four different gene therapy approaches are currently in Phase I or Phase II clinical trials. Some approaches are intended to increase levels of endogenous dopamine or enhance the function of the prodrug levodopa. Others are intended to normalize basal ganglia circuitry by reducing the PD‐related overactivity of specific brain structures such as the subthalamic nucleus. Each is intended for symptomatic benefit. Finally, gene delivery of trophic factors that not only augment dopaminergic function but are potentially disease modifying has a strong preclinical database and are also in clinical trials. Each of these approaches is discussed in the present review. © 2010 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Suède</li><li>États-Unis</li></country></list><tree><country name="Suède"><noRegion><name sortKey="Bjorklund, Tomas" sort="Bjorklund, Tomas" uniqKey="Bjorklund T" first="Tomas" last="Bjorklund">Tomas Bjorklund</name></noRegion></country><country name="États-Unis"><noRegion><name sortKey="Kordower, Jeffrey H" sort="Kordower, Jeffrey H" uniqKey="Kordower J" first="Jeffrey H." last="Kordower">Jeffrey H. Kordower</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000706 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000706 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:AAC2F34BFA188D448A90DEC60A14E1BB44F09B51
|texte= Gene therapy for Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |